Antigen-experienced CXCR5- CD19low B cells are plasmablast precursors expanded in SLE | medRxiv
Effector and regulatory B cells in immune-mediated kidney disease | Nature Reviews Nephrology
Unraveling B cell trajectories at single cell resolution: Trends in Immunology
CD antigens expression in B cells
CD19 - an overview | ScienceDirect Topics
B Cell Overview | Thermo Fisher Scientific - US
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
CD19 Function in Early and Late B Cell Development: I. Maintenance of Follicular and Marginal Zone B Cells Requires CD19-Dependent Survival Signals | The Journal of Immunology
Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram
B cells (mouse) | Mouse cell types | Mouse cells and organs | MACS Handbook | Resources | Miltenyi Biotec | USA
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Standing out from the crowd: How to identify plasma cells - Tellier - 2017 - European Journal of Immunology - Wiley Online Library
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer
-Immunohistochemistry-NB100-65672-img0001.jpg "CD19: An Undoubted Biomarker for B Cells | Antibody News: Novus Biologicals")
CD19: An Undoubted Biomarker for B Cells | Antibody News: Novus Biologicals
JCI - Genes required for B cell development
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Solved 4. CD19 is a cell-surface marker expressed in all B | Chegg.com
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
CD19 - The Marker, the Antibodies | Bio-Rad
T Cell Markers and B Cell Markers
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
What Is CD19 Antigen? – Creative Biolabs CAR-T Blog
